Healthlead PCL (BKK:HL) Selling, General, & Admin. Expense: ฿502 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BKK:HL Healthlead PCL BKK:HL
73 GF Score
Price ฿4.84
GF Value ฿9.98
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Healthlead PCL Selling, General, & Admin. Expense?

Healthlead PCL BKK:HL -1.63% 73 Selling, General, & Admin. Expense is ฿502 Mil as of Jun. 2026. GuruFocus rates BKK:HL with a GF Score™ of 73/100 and a GF Value™ of ฿9.98 (Significantly Undervalued). The stock has 3 warning signs investors should review.

Selling, general, & admin. expense (SGA) includes the direct and indirect costs and all general and administrative expenses of a company. Healthlead PCL's selling, general, & admin. expense for the three months ended in Jun. 2026 was ฿133 Mil. Its selling, general, & admin. expense for the trailing twelve months (TTM) ended in Jun. 2026 was ฿502 Mil.


Healthlead PCL  (BKK:HL) Selling, General, & Admin. Expense Explanation

An efficient operation keeps SGA costs low and thus has higher profit margin. The percentage of SGA relative to total revenue is an indication of how efficiently the company operates. Compare this percentage among the companies in the same industry is a good way of finding more efficient operations. A comparison of the SGA cost relative to the revenue with the historical value can also be an indication of how efficient the company has become.

Warren Buffett likes companies with consistent SGA as the percentage of gross profit.

Companies with no durable competitive advantage show wild variation in SG&A as % of Gross Profit.

If SGA is less than 30% of Gross Profit, it is fantastic. If SGA is nearing 100%, it is is in highly competitive industry.


Healthlead PCL Selling, General, & Admin. Expense Related Terms


Healthlead PCL Selling, General, & Admin. Expense Historical Data

* Premium members only.

The historical data trend for Healthlead PCL's Selling, General, & Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Healthlead PCL Selling, General, & Admin. Expense Chart

Healthlead PCL Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Selling, General, & Admin. Expense
Get a 7-Day Free Trial 191.31 249.52 306.94 410.04 480.85

Healthlead PCL Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Selling, General, & Admin. Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 120.54 121.63 123.82 123.75 132.65

Healthlead PCL Selling, General, & Admin. Expense Competitor Comparison

For the Pharmaceutical Retailers subindustry, Healthlead PCL's Selling, General, & Admin. Expense, along with its competitors' market caps and Selling, General, & Admin. Expense data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Healthlead PCL Selling, General, & Admin. Expense vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Healthlead PCL's Selling, General, & Admin. Expense distribution charts can be found below:

* The bar in red indicates where Healthlead PCL's Selling, General, & Admin. Expense falls into.


BKK:HL
73GF Score
Healthlead PCL BKK:HL
Selling, General, & Admin. Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Healthlead PCL Selling, General, & Admin. Expense Calculation

Selling, General, & Admin. Expense (SGA) includes the direct and indirect costs and all general and administrative expenses of a company. For instance, personnel cost, advertising, rent, communication costs are all part of SGA.

Selling, General, & Admin. Expense for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿502 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Selling, General, & Admin. Expense of ฿502 Mil mean?
Healthlead PCL (BKK:HL) has a Selling, General, & Admin. Expense of ฿502 Mil as of Jun. 2026. Selling, general and admin expense is the total cost for direct, indirect, general and administrative activities. View historical data on Healthlead PCL and its competitors.
Is Healthlead PCL's Selling, General, & Admin. Expense too high?
Healthlead PCL's current Selling, General, & Admin. Expense is ฿502 Mil. Overall, Healthlead PCL has a GF Score™ of 73/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Healthlead PCL's Selling, General, & Admin. Expense compare to competitors?
Healthlead PCL's Selling, General, & Admin. Expense of ฿502 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Selling, General, & Admin. Expense for a Healthcare Providers & Services company?
A good Selling, General, & Admin. Expense depends on the Healthcare Providers & Services industry context. However, Selling, General, & Admin. Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Selling, General, & Admin. Expense mean?
A high Selling, General, & Admin. Expense can signal that a stock is expensive relative to its fundamentals. Selling, general and admin expense is the total cost for direct, indirect, general and administrative activities. View historical data on Healthlead PCL and its competitors. Healthlead PCL's current Selling, General, & Admin. Expense is ฿502 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Healthlead PCL stock overvalued right now?
Based on GuruFocus' analysis, Healthlead PCL (BKK:HL) is currently considered Significantly Undervalued. The stock's GF Value™ is ฿9.98, compared to a current price of ฿4.84 — trading 51.5% below its estimated fair value. The current Selling, General, & Admin. Expense is ฿502 Mil. Healthlead PCL's overall GF Score™ is 73/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Selling, General, & Admin. Expense calculated?
Selling, General, & Admin. Expense is calculated from a company's financial statements. For Healthlead PCL (BKK:HL), the current Selling, General, & Admin. Expense is ฿502 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Healthlead PCL (BKK:HL) Overvalued in 2026?

Based on GuruFocus' analysis, Healthlead PCL stock appears to be undervalued. The current stock price of ฿4.84 is trading 51.5% below its estimated GF Value™ of ฿9.98. GuruFocus considers Healthlead PCL to be Significantly Undervalued.

Key valuation signals for BKK:HL:

  • Selling, General, & Admin. Expense: ฿502 Mil
  • GF Value™: ฿9.98 vs. price of ฿4.84 (51.5% below fair value)
  • GF Score™: 73/100 with 3 warning signs

No single metric tells the full story. See the BKK:HL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Healthlead PCL Business Description

Address 99/4 Moo 10, Bang Muang Sub-District, Bang-Yai District, Nonthaburi, THA, 11140
Healthlead PCL is a holding company. Along with its subsidiaries, it operates a pharmacy business under iCare, Pharmax, vitaminclub, and Super Drug brands, distributing medicines, medical supplies, cosmeceuticals, dietary supplements, medical devices, and other healthcare products. Additionally, it is involved in co-inventing and co-developing healthcare products in collaboration with external research teams and contract manufacturers, producing and distributing its own branded products. Geographically, the group operates only in Thailand.
73GF Score

Get the complete analysis for BKK:HL

Selling, General, & Admin. Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

฿4.84
Price
฿9.98
GF Value